Why This Matters for Your Career
Merck & Co. is hiring 10 roles related to this product
PROPRANOLOL HYDROCHLORIDE (propranolol hydrochloride) by Merck & Co. is mechanism of action the mechanism of the antihypertensive effect of propranolol has not been established. Approved for common migraine headache, tremor associated with parkinsonism, the management of hypertension and 6 more indications. First approved in 1985.
Mechanism of Action The mechanism of the antihypertensive effect of propranolol has not been established. Factors that may contribute to the antihypertensive action include: (1) decreased cardiac output, (2) inhibition of renin release by the kidneys, and (3) diminution of tonic sympathetic nerve…
Worked on PROPRANOLOL HYDROCHLORIDE at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Propranolol Hydrochloride in Combination With Sintilimab and Platinum-based Chemotherapy for Treatment of Advanced Non-small Cell Lung Cancer
Merck & Co. is hiring 10 roles related to this product